Open access · CC-BY
via OpenAlex
Anti-Cancer Immunotherapies Targeting Telomerase
Simone Negrini, Raffaele De Palma, Gilberto Filaci
Cancers · 2020 · ▲ 58 citations
Abstract
Telomerase is a reverse transcriptase that maintains telomeres length, compensating for the attrition of chromosomal ends that occurs during each replication cycle. Telomerase is expressed in germ cells and stem cells, whereas it is virtually undetectable in adult somatic cells. On the other hand, telomerase is broadly expressed in the majority of human tumors playing a crucial role in the replicative behavior and immortality of cancer cells. Several studies have demonstrated that telomerase-derived peptides are able to bind to HLA (human leukocyte antigen) class I and class II molecules and effectively activate both CD8+ and CD4+ T cells subsets. Due to its broad and selective expression in cancer cells and its significant immunogenicity, telomerase is considered an ideal universal tumor-associated antigen, and consequently, a very attractive target for anti-cancer immunotherapy. To date, different telomerase targeting immunotherapies have been studied in pre-clinical and clinical settings, these approaches include peptide vaccination and cell-based vaccination. The objective of this review paper is to discuss the role of human telomerase in cancer immunotherapy analyzing recent developments and future perspectives in this field.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/cancers12082260
- Canonical
- link ↗
- Fetched
- 2026-06-22 MST
Cite this
APA
Negrini, S., Palma, R.D., & Filaci, G. (2020). Anti-Cancer Immunotherapies Targeting Telomerase. <em>Cancers</em>. https://doi.org/10.3390/cancers12082260
Vancouver
Negrini S, Palma RD, Filaci G. Anti-Cancer Immunotherapies Targeting Telomerase. Cancers. 2020. doi:10.3390/cancers12082260.
BibTeX
@article{simone2020AntiCa,
title = {Anti-Cancer Immunotherapies Targeting Telomerase},
author = {Simone Negrini and Raffaele De Palma and Gilberto Filaci},
journal = {Cancers},
year = {2020},
doi = {10.3390/cancers12082260},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Mini-Reviews in Organic Chemistry 2016
Citation only
Telomerase Inhibitors: Potential Anticancer Agents
Journal of Cellular and Molecular Medicine 2011
Open access · OA
Targeting telomerase-expressing cancer cells
International Journal of Molecular Sciences 2019
Open access · CC-BY
Telomerase-Targeted Cancer Immunotherapy
Viruses 2017
Open access · CC-BY
Telomerase Induction in HPV Infection and Oncogenesis
Humana Press eBooks 2009
Citation only
Telomere and Telomerase for the Regulation of Stem Cells
Cancer Cell 2008
Open access · OA